Respiratory syncytial virus (RSV) - World Health Organization (WHO)
Respiratory syncytial virus (RSV) World Health Organization (WHO)
RSV (Respiratory Syncytial Virus) News
How RSV Spreads - Centers for Disease Control and Prevention | CDC (.gov)
How RSV Spreads Centers for Disease Control and Prevention | CDC (.gov)
Respiratory syncytial virus (RSV) in adults: risk and vaccination - Hospital Clínic Barcelona
Respiratory syncytial virus (RSV) in adults: risk and vaccination Hospital Clínic Barcelona
RSV In Infants: Why Early Awareness Can Save Lives - Africa.com
RSV In Infants: Why Early Awareness Can Save Lives Africa.com
Nirsevimab may protect babies from severe RSV better than maternal vaccination - cidrap.umn.edu
Nirsevimab may protect babies from severe RSV better than maternal vaccination cidrap.umn.edu
Triple Viral Respiratory Co-Infection With Respiratory Syncytial Virus (RSV), Human Metapneumovirus (HMPV), and Influenza A (H1N1) Leading to Acute Respiratory Distress Syndrome (ARDS) in an Infant: A Case Report - Cureus
Triple Viral Respiratory Co-Infection With Respiratory Syncytial Virus (RSV), Human Metapneumovirus (HMPV), and Influenza A (H1N1) Leading to Acute Respiratory Distress Syndrome (ARDS) in an Infant: A Case Report Cureus
Respiratory syncytial virus (RSV) Infant Monoclonal Antibody Administration Extension - KDHE (.gov)
Respiratory syncytial virus (RSV) Infant Monoclonal Antibody Administration Extension KDHE (.gov)
Respiratory virus vaccines: Clinical guidance and resources - American Academy of Family Physicians | AAFP
Respiratory virus vaccines: Clinical guidance and resources American Academy of Family Physicians | AAFP
The soluble G protein of respiratory syncytial virus promotes viral dissemination via TLR2-mediated NLRP3 priming and pyroptosis - Nature
The soluble G protein of respiratory syncytial virus promotes viral dissemination via TLR2-mediated NLRP3 priming and pyroptosis Nature
Respiratory syncytial virus (RSV) antibody and small-molecule drugs: current status of clinical translation and challenges - Frontiers
Respiratory syncytial virus (RSV) antibody and small-molecule drugs: current status of clinical translation and challenges Frontiers
Respiratory Syncytial Virus (RSV): A Comprehensive Overview From Basic Biology to Clinical Prevention and Control - Wiley Online Library
Respiratory Syncytial Virus (RSV): A Comprehensive Overview From Basic Biology to Clinical Prevention and Control Wiley Online Library
Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75–79 years in England: a multicentre, test-negative, case–control study - The Lancet
Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75–79 years in England: a multicentre, test-negative, case–control study The Lancet
Current and Emerging Strategies for the Prevention of Respiratory Syncytial Virus (RSV) Infections: A Comprehensive Review of Vaccines and Antibody Therapies - Cureus
Current and Emerging Strategies for the Prevention of Respiratory Syncytial Virus (RSV) Infections: A Comprehensive Review of Vaccines and Antibody Therapies Cureus
Interactions of SARS-CoV-2, influenza and respiratory syncytial virus influence epidemic timing and risk - Nature
Interactions of SARS-CoV-2, influenza and respiratory syncytial virus influence epidemic timing and risk Nature
RSV symptoms in older adults often linger, studies show - cidrap.umn.edu
RSV symptoms in older adults often linger, studies show cidrap.umn.edu
The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation - The Lancet
The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation The Lancet
-adrenergic signaling controls neonatal respiratory syncytial virus infection by promoting viral clearance and airway protection - Nature
-adrenergic signaling controls neonatal respiratory syncytial virus infection by promoting viral clearance and airway protection Nature
The Evolving Landscape of Respiratory Syncytial Virus (RSV) Prophylaxis in Infants - Cureus
The Evolving Landscape of Respiratory Syncytial Virus (RSV) Prophylaxis in Infants Cureus
Correlates of risk of respiratory syncytial virus disease: a prospective cohort study - Nature
Correlates of risk of respiratory syncytial virus disease: a prospective cohort study Nature
Short-term environmental changes and respiratory syncytial virus infection in Chile - Nature
Short-term environmental changes and respiratory syncytial virus infection in Chile Nature
RSV Is Still Surging in These 9 States, Hitting Kids Under 4 the Hardest. When Will the Season End? - TODAY.com
RSV Is Still Surging in These 9 States, Hitting Kids Under 4 the Hardest. When Will the Season End? TODAY.com
Real-time prediction of influenza and respiratory syncytial virus epidemics in primary care using the Gompertz model - Nature
Real-time prediction of influenza and respiratory syncytial virus epidemics in primary care using the Gompertz model Nature
Analysis of DNA methyltransferase 3 alpha expression during respiratory syncytial virus strain A infection - Nature
Analysis of DNA methyltransferase 3 alpha expression during respiratory syncytial virus strain A infection Nature
Guillain-Barré Syndrome Following Respiratory Syncytial Virus (RSV) Infection in the Third Trimester: A Case Report of a Rare Entity - Cureus
Guillain-Barré Syndrome Following Respiratory Syncytial Virus (RSV) Infection in the Third Trimester: A Case Report of a Rare Entity Cureus
In 2023-24, RSV vaccines were 79% effective against virus-related blood clots in older adults, CDC estimates - cidrap.umn.edu
In 2023-24, RSV vaccines were 79% effective against virus-related blood clots in older adults, CDC estimates cidrap.umn.edu
Immunogenicity and reactogenicity of the adjuvanted respiratory syncytial virus vaccine in patients with chronic kidney disease - medRxiv
Immunogenicity and reactogenicity of the adjuvanted respiratory syncytial virus vaccine in patients with chronic kidney disease medRxiv
Respiratory syncytial virus (RSV) resources - American Medical Association
Respiratory syncytial virus (RSV) resources American Medical Association
Respiratory Syncytial Virus (RSV) Vaccine Safety - Centers for Disease Control and Prevention | CDC (.gov)
Respiratory Syncytial Virus (RSV) Vaccine Safety Centers for Disease Control and Prevention | CDC (.gov)
RSV facts you need to know: What to expect during its winter peak - UT Physicians
RSV facts you need to know: What to expect during its winter peak UT Physicians
Respiratory syncytial virus (RSV) tied to heart problems - Harvard Health
Respiratory syncytial virus (RSV) tied to heart problems Harvard Health
COMMENTARY: The importance of RSV vaccination: Why now is the time to plan ahead - Jefferson City News Tribune
COMMENTARY: The importance of RSV vaccination: Why now is the time to plan ahead Jefferson City News Tribune
Nirsevimab may help prevent severe respiratory illnesses beyond RSV in infants, young kids - cidrap.umn.edu
Nirsevimab may help prevent severe respiratory illnesses beyond RSV in infants, young kids cidrap.umn.edu
Hospitalisation and healthcare burden of respiratory syncytial virus in adults over 50 years in France - medRxiv
Hospitalisation and healthcare burden of respiratory syncytial virus in adults over 50 years in France medRxiv
Whole-genome nanopore sequencing and automatic downstream analysis of respiratory syncytial virus using RSVTyper - Nature
Whole-genome nanopore sequencing and automatic downstream analysis of respiratory syncytial virus using RSVTyper Nature
Notes from the Field: Expanding Birthing Hospital ... - Centers for Disease Control and Prevention | CDC (.gov)
Notes from the Field: Expanding Birthing Hospital ... Centers for Disease Control and Prevention | CDC (.gov)
Merck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease Over Two RSV Seasons - Yahoo Finance
Merck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease Over Two RSV Seasons Yahoo Finance
RSV vaccine protects older adults, and drug protects babies, but less so over time, studies suggest - cidrap.umn.edu
RSV vaccine protects older adults, and drug protects babies, but less so over time, studies suggest cidrap.umn.edu
RSV tied to heart problems, breathing issues well after infection in adults - cidrap.umn.edu
RSV tied to heart problems, breathing issues well after infection in adults cidrap.umn.edu
Earlier and prolonged respiratory syncytial virus (RSV) seasons in young children compared to adults: implications for prevention in infants - ASM Journals
Earlier and prolonged respiratory syncytial virus (RSV) seasons in young children compared to adults: implications for prevention in infants ASM Journals
Reoccurring Salmonella Cotham Outbreak Linked... - Centers for Disease Control and Prevention | CDC (.gov)
Reoccurring Salmonella Cotham Outbreak Linked... Centers for Disease Control and Prevention | CDC (.gov)